Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Abnormal Uterine Bleeding: early-phase trial registry
2 of 3 indexed Abnormal Uterine Bleeding trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Abnormal Uterine Bleeding: 3 US clinical trials tracked, 2 recruiting.
Abnormal Uterine Bleeding is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Channel Medsystems, running 1 of these trials.
Enrollment posture brief
Registry condition abnormal-uterine-bleeding
OPEN 2 | RECR 67% | LATE 0 | EARLY 1 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
Abnormal Uterine Bleeding lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Abnormal Uterine Bleeding on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Abnormal Uterine Bleeding is recruiting above its size-band peers.
2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
A Registry to Gather Real World Use Data on the Cerene® Cryotherapy Device
Channel Medsystems
NCT05922657
Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy
Icahn School of Medicine at Mount Sinai
NCT06653400
Decisionmaking for Abnormal Uterine Bleeding (AUB)
Indiana University
NCT01721304
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Abnormal Uterine Bleeding records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Abnormal Uterine Bleeding trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Abnormal Uterine Bleeding page
3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Abnormal Uterine Bleeding trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Channel Medsystems sponsors the most Abnormal Uterine Bleeding trials on record, review their full trial history before evaluating a specific study. See Channel Medsystems's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Abnormal Uterine Bleeding condition card totals 3 registered trials; most-linked intervention Adaptive Conjoint Analysis; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.